naltrexone targets alcoholism

Subject: naltrexone
Relation: targets
Object: alcoholism
p-value: —

Evidence from: primary | all sources

Evidence (2 sources)

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited

approved by the FDA for treating patients with AUD who are able to abstain from alcohol

confidence: 0.92

Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. (2009) PMID:19485973 cited

naltrexone was superior to placebo on a number of drinking outcome variables

confidence: 0.93